Mostrar el registro sencillo del ítem
| dc.contributor.author | Álvarez-García, Francisco-José | |
| dc.contributor.author | Iofrío-de-Arce, Antonio | |
| dc.contributor.author | Álvarez-Aldean, Javier | |
| dc.contributor.author | Garrote-Llanos, Elisa | |
| dc.contributor.author | López-Granados, Lucía | |
| dc.contributor.author | Navarro-Gómez, María-Luisa | |
| dc.contributor.author | Pineda-Solas, Valentín | |
| dc.contributor.author | Rivero-Calle, Irene | |
| dc.contributor.author | Ruiz-Contreras, Jesús | |
| dc.contributor.author | Salamanca-de-la-Cueva, Ignacio | |
| dc.contributor.author | Serrano-Marchuet, Pepe | |
| dc.date.accessioned | 2026-04-20T09:43:30Z | |
| dc.date.available | 2026-04-20T09:43:30Z | |
| dc.date.issued | 2026-01 | |
| dc.identifier.citation | José Álvarez García F, Iofrío De Arce A, Álvarez Aldeán J, Garrote Llanos E, López Granados L, Navarro Gómez ML, et al. Vaccination and immunization schedule of the Pediatric Spanish Association: 2026 recommendations. Anales de Pediatría (English Edition). enero de 2026;104(1):504051. doi:10.1016/j.anpede.2025.504051 | |
| dc.identifier.uri | https://sms.carm.es/ricsmur/handle/123456789/25901 | |
| dc.description.abstract | The 2026 Vaccination and Immunization Schedule recommended by the Spanish Association of Pediatrics (AEP) for children, adolescents and pregnant women residing in Spain includes the following new features: introduction of routine vaccination against hepatitis A with a single-dose schedule at 12-15 months; universal vaccination against influenza in children from 6 months and adolescents up to 17 years of age; catch-up vaccination and reengagement campaigns added to the routine immunization schedule and a new table featuring the vaccinations recommended for specific chronic diseases or risk conditions. The following recommendations from the 2025 schedule, among others, are maintained: immunization with nirsevimab in infants younger than 6 months, or up to 12 months in the case of preterm infants born before 35 weeks of gestation and up to 24 months in children with risk factors; routine vaccination against meningococcal disease (MenB in infancy [starting at 2 months] and at 12 years, plus booster doses for those vaccinated in childhood with 4CMenB; MenACWY at 4 months, 12 months and 12 years); advancing the second doses of MMR and varicella vaccines to 24 months and the Tdap at 10-12 years; and vaccination against SARS-CoV-2 for children older than 6 months with risk factors. During pregnancy, vaccination with Tdap and against influenza and COVID-19 is indicated. Vaccination against RSV in pregnant women is available, although not funded, as it is not currently approved as a public health strategy. | |
| dc.language.iso | eng | |
| dc.publisher | ELSEVIER | |
| dc.rights | Atribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional | |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es | * |
| dc.subject.mesh | Adolescent | |
| dc.subject.mesh | Child | |
| dc.subject.mesh | Child, Preschool | |
| dc.subject.mesh | Female | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Infant | |
| dc.subject.mesh | Infant, Newborn | |
| dc.subject.mesh | Immunization Schedule | |
| dc.subject.mesh | Pediatrics | |
| dc.subject.mesh | Spain | |
| dc.subject.mesh | Vaccination/standards | |
| dc.subject.mesh | Male | |
| dc.title | Vaccination and immunization schedule of the Pediatric Spanish Association: 2026 recommendations. | |
| dc.type | info:eu-repo/semantics/article | |
| dc.identifier.pmid | 41577399 | |
| dc.relation.publisherversion | https://linkinghub.elsevier.com/retrieve/pii/S2341287925004533 | |
| dc.type.version | info:eu-repo/semantics/publishedVersion | |
| dc.identifier.doi | 10.1016/j.anpede.2025.504051 | |
| dc.journal.title | Anales de Pediatría | |
| dc.identifier.essn | 2341-2879 |